Phillies rumours: Jose Alvarado’s “selfish” replacement might cost $72 million
The Philadelphia Phillies are navigating a significant bullpen challenge following the 80 game suspension of star reliever José Alvarado for a performance-enhancing drug violation. Alvarado, who had a 2.70 ERA and seven saves in 20 innings this season, is now ineligible for the playoffs, leaving a void in the team’s late-inning pitching strategy.
In response, the Phillies are reportedly considering a reunion with veteran right-hander David Robertson. The 40years old free agent, who previously pitched for Philadelphia in 2019 and 2022, posted a solid 3.00 ERA with 99 strikeouts over 72 innings last season with the Texas Rangers. Despite his age, Robertson’s experience and recent performance make him a viable option to stabilize the bullpen.
However, the potential financial implications of acquiring a high-profile replacement have sparked discussions. Some analysts suggest that pursuing a top-tier reliever could cost the Phillies up to $72 million, a figure that raises concerns about the team’s payroll flexibility. This scenario draws parallels to past contracts, such as the four-year, $72 million deal signed by Taijuan Walker, highlighting the risks associated with significant financial commitments to pitchers.
Internally, the Phillies are also evaluating other options. Relievers like Jordan Romano and Orion Kerkering have shown improvement, with Romano not allowing a run in his last eight appearances and Kerkering limiting opponents to one run across seven outings in May. Additionally, left-handed reliever Taylor Rogers, recently placed on waivers by the San Francisco Giants, presents a cost-effective alternative. Rogers boasts a 2.45 ERA and 59 strikeouts in 51⅓ innings this season, making him an attractive option for bolstering the bullpen without a substantial financial outlay.
As the Phillies (29-18) lead the NL East, the front office faces critical decisions to maintain their competitive edge. Balanci
